| Products/Services Used | Details | Operation |
|---|---|---|
| Gene Synthesis | also receives licensing fees (to patents in which he was an inventor on) from, invested in, consults (or was on scientific advisory boards or boards of directors) for, lectured (and received a fee), or conducts sponsored research at MIT for which he was not paid for the following entities: 7th Sense, Abpro, Aleph Farms, Alkermes, Allevi, Alnylam, Arcadia Biosciences, Artificial Cells, Arsenal Medical, Avalon, BASF, Celero, Cellomics, Cellular Biomedical, Charles River Labs, Clarus, Clontech, Combined Therapeutics, Conference Forum, Crown Biosciences, Curis, Cygnal Therapeutics, Dewpoint, Domain, Eagle, Echo, Edigene, Editas, Evox, Fate Therapeutics, Frequency Therapeutics, Genscript, GlaxoSmithKline, Glycobia, Glympse, Greenlight, HKF Technologies, Horizon Discovery, Humacyte, Indivor, Inovio, Institute of Immunology, Integrated DNA Technologies, In Vivo Therapeutics, Jnana Therapeutics, Kensa, KSQ Therapeutics, Laderatech, Inc. | Get A Quote |
Encapsulated beta cell transplantation offers a potential cure for a subset of diabetic patients. Once transplanted, beta cell grafts can help to restore glycemic control; however, locating and retrieving cells in the event of graft failure may pose a surgical challenge. Here, a dual-function nanoparticle-loaded hydrogel microcapsule is developed that enables graft retrieval under an applied magnetic field. Additionally, this system facilitates graft localization via magnetic resonance imaging (MRI), and graft isolation from the immune system. Iron oxide nanoparticles encapsulated within alginate hydrogel capsules containing viable islets are transplanted and the in vitro and in vivo retrieval of capsules conta... More
